Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children

被引:10
作者
Ankola, Ashish A. [1 ]
Bradford, Victoria R. [2 ]
Newburger, Jane W. [3 ]
Emani, Sirisha [4 ]
Dionne, Audrey [3 ]
Friedman, Kevin [3 ]
Son, Mary Beth [5 ]
Henderson, Lauren A. [5 ]
Lee, Pui Y. [5 ]
Hellinger, Amy [3 ]
Hawkins, Beth [3 ]
Ventresco, Courtney [3 ]
Esteso, Paul [3 ]
VanderPluym, Christina J. [3 ]
机构
[1] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA
[2] Boston Childrens Hosp, Dept Pediat, Boston, MA USA
[3] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA
[4] Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA USA
[5] Boston Childrens Hosp, Div Immunol, Boston, MA USA
关键词
COVID-19; MIS-C; thromboelastography; thrombosis; KAWASAKI-DISEASE; HEMOSTASIS; DEFINITION; MANAGEMENT; DIAGNOSIS; COVID-19;
D O I
10.1002/pbc.29355
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective To characterize viscoelastic testing profiles of children with multisystem inflammatory syndrome in children (MIS-C). Methods This single-center retrospective review included 30 patients diagnosed with MIS-C from March 1 to September 1, 2020. Thromboelastography (TEG) with platelet mapping was performed in 19 (63%) patients and compared to age- and sex-matched controls prior to cardiac surgery. Relationships between TEG parameters and inflammatory markers were assessed using correlation. Results Patients with MIS-C had abnormal TEG results compared to controls, including decreased kinetic (K) time (1.1 vs. 1.7 minutes, p < .01), increased alpha angle (75.0 degrees vs. 65.7 degrees, p < .01), increased maximum amplitude (70.8 vs. 58.3 mm, p < .01), and decreased lysis in 30 minutes (Ly30) (1.1% vs. 3.7%, p = .03); consistent with increased clot formation rate and strength, and reduced fibrinolysis. TEG maximum amplitude was moderately correlated with erythrocyte sedimentation rate (ESR) (r = 0.60, p = .02), initial platelet count (r = 0.67, p < .01), and peak platelet count (r = 0.51, p = .03). TEG alpha angle was moderately correlated with peak platelet count (r = 0.54, p = .02). Seventeen (57%) patients received aspirin (ASA) and anticoagulation, five (17%) received only ASA, and three (10%) received only anticoagulation. No patients had a symptomatic thrombotic event. Six (20%) patients had a bleeding event, none of which was major. Conclusions Patients with MIS-C had evidence of hypercoagulability on TEG. Increased ESR and platelets were associated with higher clot strength. Patients were prophylactically treated with ASA or anticoagulation with no symptomatic thrombosis or major bleeding. Further multicenter study is required to characterize the rate of thrombosis and optimal thromboprophylaxis algorithm in this patient population.
引用
收藏
页数:9
相关论文
共 43 条
  • [1] Are children with SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients
    Al-Ghafry, Maha
    Aygun, Banu
    Appiah-Kubi, Abena
    Vlachos, Adrianna
    Ostovar, Gholamabbas
    Capone, Christine
    Sweberg, Tod
    Palumbo, Nancy
    Goenka, Pratichi
    Wolfe, Lawrence W.
    Lipton, Jeffrey M.
    Acharya, Suchitra S.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 (12)
  • [2] COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
    Al-Samkari, Hanny
    Leaf, Rebecca S. Karp
    Dzik, Walter H.
    Carlson, Jonathan C. T.
    Fogerty, Annemarie E.
    Waheed, Anem
    Goodarzi, Katayoon
    Bendapudi, Pavan K.
    Bornikova, Larissa
    Gupta, Shruti
    Leaf, David E.
    Kuter, David J.
    Rosovsky, Rachel P.
    [J]. BLOOD, 2020, 136 (04) : 489 - 500
  • [3] Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
    Allegra, Alessandro
    Innao, Vanessa
    Allegra, Andrea Gaetano
    Musolino, Caterina
    [J]. ANNALS OF HEMATOLOGY, 2020, 99 (09) : 1953 - 1965
  • [4] [Anonymous], 2020, LANCET HAEMATOL, V7, pE425, DOI 10.1016/S2352-3026(20)30151-4
  • [5] [Anonymous], 2020, Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States
  • [6] [Anonymous], 2008, Information for Healthcare Professionals: Micro-bubble Contrast Agents (marketed as Definity (Perflutren Lipid Microsphere) Injectable Suspension and Optison (Perflutren Protein-Type A Microspheres for Injection)
  • [7] The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review
    Aronoff, Stephen C.
    Hall, Ashleigh
    Del Vecchio, Michael T.
    [J]. JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (06) : 746 - 751
  • [8] Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic
    Belhadjer, Zahra
    Meot, Mathilde
    Bajolle, Fanny
    Khraiche, Diala
    Legendre, Antoine
    Abakka, Samya
    Auriau, Johanne
    Grimaud, Marion
    Oualha, Mehdi
    Beghetti, Maurice
    Wacker, Julie
    Ovaert, Caroline
    Hascoet, Sebastien
    Selegny, Maelle
    Malekzadeh-Milani, Sophie
    Maltret, Alice
    Bosser, Gilles
    Giroux, Nathan
    Bonnemains, Laurent
    Bordet, Jeanne
    Di Filippo, Sylvie
    Mauran, Pierre
    Falcon-Eicher, Sylvie
    Thambo, Jean-Benoit
    Lefort, Bruno
    Moceri, Pamela
    Houyel, Lucile
    Renolleau, Sylvain
    Bonnet, Damien
    [J]. CIRCULATION, 2020, 142 (05) : 429 - 436
  • [9] Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
    Bilaloglu, Seda
    Aphinyanaphongs, Yin
    Jones, Simon
    Iturrate, Eduardo
    Hochman, Judith
    Berger, Jeffrey S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (08): : 799 - 801
  • [10] Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism
    Biss, T. T.
    Brandao, L. R.
    Kahr, W. H. A.
    Chan, A. K. C.
    Williams, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (10) : 1633 - 1638